MAIMONE, SERGIO
 Distribuzione geografica
Continente #
NA - Nord America 2.144
EU - Europa 1.318
AS - Asia 1.022
SA - Sud America 358
AF - Africa 30
OC - Oceania 3
Totale 4.875
Nazione #
US - Stati Uniti d'America 2.119
SG - Singapore 418
IE - Irlanda 349
CN - Cina 337
BR - Brasile 323
SE - Svezia 298
IT - Italia 215
HK - Hong Kong 127
DE - Germania 112
FI - Finlandia 68
PL - Polonia 62
VN - Vietnam 48
RU - Federazione Russa 46
UA - Ucraina 42
GB - Regno Unito 36
IN - India 35
FR - Francia 30
AR - Argentina 16
BE - Belgio 13
CA - Canada 12
NL - Olanda 11
BD - Bangladesh 9
JP - Giappone 9
MX - Messico 9
CI - Costa d'Avorio 8
TR - Turchia 8
AT - Austria 5
CO - Colombia 5
CZ - Repubblica Ceca 5
EC - Ecuador 5
EE - Estonia 5
ES - Italia 5
ZA - Sudafrica 5
MA - Marocco 4
PK - Pakistan 4
UZ - Uzbekistan 4
CL - Cile 3
ID - Indonesia 3
IL - Israele 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
SN - Senegal 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
DZ - Algeria 2
EG - Egitto 2
JM - Giamaica 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
LV - Lettonia 2
NO - Norvegia 2
PY - Paraguay 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IQ - Iraq 1
IR - Iran 1
KG - Kirghizistan 1
KZ - Kazakistan 1
ML - Mali 1
NG - Nigeria 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TZ - Tanzania 1
UY - Uruguay 1
Totale 4.875
Città #
Ashburn 473
Dublin 349
Dallas 348
Chandler 225
Singapore 214
Nyköping 171
Beijing 138
Hong Kong 125
Jacksonville 98
Messina 71
Warsaw 58
The Dalles 57
Ann Arbor 54
Dearborn 48
Munich 46
Princeton 46
Medford 45
Los Angeles 43
Des Moines 37
Cambridge 36
New York 33
Rome 28
Turku 25
São Paulo 22
Nanjing 21
Boardman 20
Buffalo 20
Jinan 20
Moscow 20
Helsinki 17
San Mateo 17
Ho Chi Minh City 16
Redondo Beach 15
Shenyang 15
Pune 14
Woodbridge 14
Brussels 13
Tianjin 13
Rio de Janeiro 12
Hanoi 11
Hyderabad 11
Ningbo 11
Nuremberg 11
Wilmington 11
Haikou 10
Houston 10
Avola 9
Belo Horizonte 9
Bremen 9
Brooklyn 9
Düsseldorf 9
Hebei 9
Seattle 9
Abidjan 8
Guangzhou 8
Tokyo 8
Brasília 7
Catania 7
Frankfurt am Main 7
Zhengzhou 7
Amsterdam 6
Boston 6
Chicago 6
Dhaka 6
Council Bluffs 5
Orem 5
Porto Alegre 5
Stockholm 5
Brno 4
Campinas 4
Curitiba 4
Dong Ket 4
Goiânia 4
Guarulhos 4
London 4
Manchester 4
Montreal 4
Nanchang 4
Poplar 4
Querétaro 4
San Francisco 4
Santa Clara 4
Taizhou 4
Toronto 4
Vienna 4
Vittoria 4
Washington 4
Augusta 3
Chennai 3
Conselheiro Lafaiete 3
Dakar 3
Denver 3
Haiphong 3
Hangzhou 3
Jakarta 3
Jiaxing 3
Madrid 3
Maringá 3
Mexico City 3
Milan 3
Totale 3.386
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 322
Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity 192
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 188
Atrial fibrillation in patients with cirrhosis 174
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 163
Dual-source dual-energy CT in the evaluation of hepatic fractional extracellular space in cirrhosis 162
Assessment of liver stiffness in subjects affected by familial combined hyperlipidaemia with hepatic steatosis. 152
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 145
A combination of different diagnostic tools allows identification of inactive hepatitis B virus carriers at a single time point evaluation 139
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 136
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 130
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 128
Assessment of liver stifness values in subjects affected by familial combined hyperlipidemia with different degree of hepatic steatosis 122
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 119
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 119
Valutazione elastografica (fibroscan) del fegato nelle pazienti con sindrome di Turner 117
Erectile dysfunction in compensated liver cirrhosis 116
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 111
Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate 110
Fibroscan: a new non invasive method for cross-sectional and longitudinal evaluation of liver dysfunction in Turner syndrome 105
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 102
Over time evaluation of glycaemic control in direct-acting antiviral-treated hepatitis C virus/diabetic individuals with chronic hepatitis or with cirrhosis 102
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 101
Rate of hepatocellular carcinoma diagnosis in cirrhotic patients with ultrasound‑detected liver nodules 99
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 98
Evaluation of liver stiffness using transient elastography (fibroscan) in young adults with Turner syndrome. 96
Dual-energy CT quantification of fractional extracellular space in cirrhotic patients: comparison between early and delayed equilibrium phases and correlation with oesophageal varices 95
Response to the high diagnostic characteristics of HBsAg level in differentiation of Hepatitis B clinical presentations: myth or truth? 93
PRE-S GENETIC VARIANTS ARE HIGHLY PREVALENT AND SIGNIFICANTLY CORRELATE WITH LOWER LEVELS OF HBSAG IN ACTIVE HBV INFECTIONS 87
NS3 genetic variability in hepatitis C virus genotype-1b isolates from liver specimens and blood samples of treatment naïve patients with chronic hepatitis C 87
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 85
INFECTION WITH HBV PRES/S VARIANTS IS HIGHLY PREVALENT AND INFLUENCES AMOUNT OF CIRCULATING HBSAG INDEPENDENTLY OF SERUM HBV DNA LEVELS AND RESPONSE TO INTERFERON THERAPY IN CHRONIC HEPATITIS B 77
Platelet Count Does Not Predict Bleeding in Cirrhotic Patients: Results from the PRO-LIVER Study 76
Coagulation and fibrosis in chronic liver disease 74
Does HCV antiviral therapy decrease the risk of hepatocellular carcinoma? 73
Comparison of cystatin C and creatinine-based glomerular filtration rate formulas with 51Cr-EDTA clearance in patients with cirrhosis 69
Computer-assisted image analysis of liver collagen: relationship to Ishak scoring and hepatic venous pressure gradient 69
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 67
Impact of tips preliver transplantation for the outcome posttransplantation 53
Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis 53
The relationship between transient elastography and histological collagen proportionate area for assessing fibrosis in chronic viral hepatitis 51
Response to: A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial] 50
Models for non-alcoholic fatty liver disease: A link with vascular risk 49
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 49
Therapy of occult hepatitis B virus infection and prevention of reactivation. 48
Fibrosis staging in chronic hepatitis C: Analysis of discordance between transient elastography and liver biopsy 39
Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection 33
null 31
null 22
null 15
Totale 4.993
Categoria #
all - tutte 18.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 20 15 31 46 29 15 15
2021/2022351 5 42 12 21 21 2 18 10 2 68 46 104
2022/2023945 71 102 39 60 64 87 19 50 413 4 22 14
2023/2024458 19 33 11 21 20 62 1 221 2 22 8 38
2024/20251.097 24 29 13 68 30 37 46 205 286 78 116 165
2025/20261.276 210 265 311 178 284 28 0 0 0 0 0 0
Totale 4.993